@article{TAU10590,
author = {Moshe C. Ornstein and Jorge A. Garcia and Nima Sharifi},
title = {Screening for functional kinases in metastatic prostate cancer: a glimmer of hope for kinase inhibition},
journal = {Translational Andrology and Urology},
volume = {5},
number = {4},
year = {2016},
keywords = {},
abstract = {Understanding the molecular biology of castration-resistant prostate cancer (CRPC) has led to a dramatic paradigm shift in the treatment of patients with metastatic disease where the androgen receptor (AR) is a central therapeutic target in the disease. Despite these major advances, disease biology and the well-recognized heterogeneity of prostate cancer (PCa) are some of the inherent disease-specific issues that continue to affect clinical trial design, drug development and ultimately patient outcomes.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/10590}
}